115 related articles for article (PubMed ID: 38565413)
1. MiR-3682-3p promotes esophageal cancer progression by targeting FHL1 and activating the Wnt/β-catenin signaling pathway.
Cai Y; Xia L; Zhu H; Cheng H; Tian Y; Sun L; Wang J; Lu N; Wang J; Chen Y
Cell Signal; 2024 Jul; 119():111155. PubMed ID: 38565413
[TBL] [Abstract][Full Text] [Related]
2. miR-33a-5p inhibits the progression of esophageal cancer through the DKK1-mediated Wnt/β-catenin pathway.
Song Q; Liu H; Li C; Liang H
Aging (Albany NY); 2021 Aug; 13(16):20481-20494. PubMed ID: 34426559
[TBL] [Abstract][Full Text] [Related]
3. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
5. IGF2-derived miR-483-3p associated with Hirschsprung's disease by targeting FHL1.
Zhi Z; Zhu H; Lv X; Lu C; Li Y; Wu F; Zhou L; Li H; Tang W
J Cell Mol Med; 2018 Oct; 22(10):4913-4921. PubMed ID: 30073757
[TBL] [Abstract][Full Text] [Related]
6. MiR-455-3p inhibits gastric cancer progression by repressing Wnt/β-catenin signaling through binding to ARMC8.
Zhan T; Chen M; Liu W; Han Z; Zhu Q; Liu M; Tan J; Liu J; Chen X; Tian X; Huang X
BMC Med Genomics; 2023 Jul; 16(1):155. PubMed ID: 37400847
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
8. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
Xu H; Li B
Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
[TBL] [Abstract][Full Text] [Related]
11. Circ_0003732 promotes osteosarcoma progression through regulating miR-377-3p/CPEB1 axis and Wnt/β-catenin signaling pathway.
Zhou Z; Liu T; Li Z; Wang L
Anticancer Drugs; 2022 Jan; 33(1):e299-e310. PubMed ID: 34407049
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
[TBL] [Abstract][Full Text] [Related]
14. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
15. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway.
Fu C; Wang S; Jin L; Zhang M; Li M
Curr Eye Res; 2021 Jul; 46(7):978-987. PubMed ID: 33108919
[No Abstract] [Full Text] [Related]
16. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
Guan B; Ma J; Yang Z; Yu F; Yao J
Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway.
Liu Q; Zhang W; Luo L; Han K; Liu R; Wei S; Guo X
Diagn Pathol; 2021 May; 16(1):47. PubMed ID: 34030715
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.
Poodineh J; Sirati-Sabet M; Rajabibazl M; Ghasemian M; Mohammadi-Yeganeh S
Chem Biol Drug Des; 2022 Sep; 100(3):334-345. PubMed ID: 35797350
[TBL] [Abstract][Full Text] [Related]
19. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p.
Zhou Y; Jin Z; Wang C
Biomed Pharmacother; 2019 Dec; 120():109449. PubMed ID: 31627092
[TBL] [Abstract][Full Text] [Related]
20. CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway.
Dong L; Qu F
J Mol Histol; 2020 Aug; 51(4):329-340. PubMed ID: 32472335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]